QuantumCyte, Inc. logo — Sample in. Clarity out.

QuantumCyte, Inc.

Sample in. Clarity out.

Founded 2013 United States Fremont, United States 15 employees Unknown Total: $1.05M Biotechnology, Life Sciences

General Information

Company Name QuantumCyte, Inc.
Founded Year 2013
Location United States Fremont, United States +1
Employees 15
Industries Biotechnology, Life Sciences
Funding Stage Unknown
Social

Get notified when QuantumCyte, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About QuantumCyte, Inc.

QuantumCyte, Inc., founded in 2013, is a transformative player in the Biotechnology and Life Sciences industries, headquartered in the United States. Their innovative approach bridges the gap between digital pathology, spatial biology, and molecular testing, promising to convert every biopsy into a rich source of insight.

With their flagship product, QCPRECISE, QuantumCyte, Inc. facilitates enhanced decision-making in research, diagnostics, and therapeutic development by converting image-based annotations into molecular clarity. This approach empowers stakeholders at every level to make faster and more confident decisions, addressing one of modern medicine's crucial needs.

The firm recently secured a $1.05M Early VC investment in August 2023. Their team's combined expertise in genomics, diagnostics, software engineering, and product development makes them a formidable player in advancing health technologies.

Taxonomy: NextGen Microdissection Platform, technology platform company, in-situ lysis, automated tissue dissection system, digital tissue maps, ROIs, informative biomarkers, precision medicine, biopharma, NGS, Molecular Pathology, clinical diagnostics, spatial profiling

Services & Products

Tissue slide transformation
High-purity molecular sampling
Integrated precision diagnostics
AI-powered pathology integration

Target Customers

Research Labs Clinical Labs Pharmaceutical Companies Precision Medicine Innovators Healthcare Providers

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Early VC •••••• - 01 Aug 2023
Convertible Note •••••• 2
Investor Investor
01 Feb 2022
Convertible Note •••••• 2
Investor Investor
01 Jun 2021
Convertible Note •••••• - 01 Jun 2019
Convertible Note •••••• 2
Investor Investor
01 Mar 2018

View All 6 Funding Rounds

QuantumCyte, Inc. Alternatives & Competitors

View All Alternatives
QuantumCyte, Inc. vs

Pioneering molecular diagnostics for oncology with the first FDA-cleared microarray-based gene expre...

Series Unknown
Biotechnology, Health Care
QuantumCyte, Inc. vs

3D tissue imaging data for spatial biology

Grant
30 employees
Life Sciences, VR/AR
QuantumCyte, Inc. vs
Seegene Inc.
Seegene Inc. Korea South

See Ahead. Change Tomorrow.

Series Unknown
486 employees
Biotechnology

FAQ About QuantumCyte, Inc.

Sample in. Clarity out.
QuantumCyte, Inc. was founded in 2013.
QuantumCyte, Inc. is headquartered in Fremont, United States.
QuantumCyte, Inc. operates in the following industries: Biotechnology, Life Sciences.
QuantumCyte, Inc. has approximately 15 employees.
QuantumCyte, Inc. has completed 6 funding rounds, raising a total of $1.05M. The latest funding stage is Unknown.
QuantumCyte, Inc. offers: Tissue slide transformation, High-purity molecular sampling, Integrated precision diagnostics, AI-powered pathology integration.
Top alternatives and competitors to QuantumCyte, Inc. include Pathwork Diagnostics, Alpenglow Biosciences, Seegene Inc., Anchor Molecular, Keen Eye Technologies. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
QuantumCyte, Inc. and Pathwork Diagnostics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors QuantumCyte, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy